Position in PEN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$253,547
-$3,130,634 QoQ
Shares Held
803
-92.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#322
of 445 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026STRS OHIO holds $225,180,169 across 40 Medical Devices names. PEN ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
480,152 | $43,568,992 | |
| 2 | MDT |
Medtronic plc
|
494,498 | $38,684,578 | |
| 3 | SYK |
Stryker Corp
|
103,692 | $32,646,389 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
412,689 | $26,416,222 | |
| 5 | BSX |
Boston Scientific Corp
|
450,236 | $19,216,072 | |
| 6 | STE |
STERIS plc
|
87,456 | $18,415,609 | |
| 7 | DXCM |
Dexcom Inc
|
188,575 | $12,700,526 | |
| 8 | EW |
Edwards Lifesciences Corp
|
120,629 | $10,912,099 |
All Filings in PEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,547 | 803 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,384,181 | 10,306 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,822,949 | 12,296 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,520,856 | 21,794 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,441,073 | 32,892 | Shares | Sole | 2025-08-04 | |
| 2023-09-30 | $830,960 | 3,435 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $986,764 | 2,868 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $949,775 | 3,408 | Shares | Sole | 2023-08-02 | |
| 2020-12-31 | $1,142,575 | 6,529 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,011,164 | 5,202 | Shares | Sole | 2020-12-14 | |
| 2020-03-31 | $417,522 | 2,588 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||